Selected research
Industry Research
Ephedrine Industry Research Report 2026
Market perspective
The global Ephedrine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ephedrine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ephedrine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ephedrine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ephedrine include Malladi Drugs＆Pharmaceuticals, Medarex, Servier, Amgen, GlaxoSmithKline, Pfizer, Roche, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ephedrine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ephedrine Market by Company
Malladi Drugs＆Pharmaceuticals
Medarex
Servier
Amgen
GlaxoSmithKline
Pfizer
Roche
Merck
Novartis
Sanofi
Ephedrine Segment by Type
Injection
Tablet
Capsule
Ephedrine Segment by Application
Recreational use
Medical use
Other uses
Ephedrine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ephedrine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ephedrine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ephedrine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ephedrine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ephedrine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ephedrine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Capsule
Applications
- Recreational use
- Medical use
- Other uses
Companies covered
- Malladi Drugs＆Pharmaceuticals
- Medarex
- Servier
- Amgen
- GlaxoSmithKline
- Pfizer
- Roche
- Merck
- Novartis
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ephedrine Market Size (2021-2032)
- 2.2.2 Global Ephedrine Sales (2021-2032)
- 2.2.3 Global Ephedrine Market Average Price (2021-2032)
- 2.3 Ephedrine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablet
- 2.3.4 Capsule
- 2.4 Ephedrine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recreational use
- 2.4.3 Medical use
- 2.4.4 Other uses
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ephedrine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ephedrine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ephedrine Revenue of Manufacturers (2021-2026)
- 3.4 Global Ephedrine Average Price by Manufacturers (2021-2026)
- 3.5 Global Ephedrine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ephedrine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ephedrine, Product Type & Application
- 3.8 Global Manufacturers of Ephedrine, Established Date
- 3.9 Global Ephedrine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Malladi Drugs＆Pharmaceuticals
- 4.1.1 Malladi Drugs＆Pharmaceuticals Company Information
- 4.1.2 Malladi Drugs＆Pharmaceuticals Business Overview
- 4.1.3 Malladi Drugs＆Pharmaceuticals Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Malladi Drugs＆Pharmaceuticals Ephedrine Product Portfolio
- 4.1.5 Malladi Drugs＆Pharmaceuticals Recent Developments
- 4.2 Medarex
- 4.2.1 Medarex Company Information
- 4.2.2 Medarex Business Overview
- 4.2.3 Medarex Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medarex Ephedrine Product Portfolio
- 4.2.5 Medarex Recent Developments
- 4.3 Servier
- 4.3.1 Servier Company Information
- 4.3.2 Servier Business Overview
- 4.3.3 Servier Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Servier Ephedrine Product Portfolio
- 4.3.5 Servier Recent Developments
- 4.4 Amgen
- 4.4.1 Amgen Company Information
- 4.4.2 Amgen Business Overview
- 4.4.3 Amgen Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Amgen Ephedrine Product Portfolio
- 4.4.5 Amgen Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Ephedrine Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Ephedrine Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Roche
- 4.7.1 Roche Company Information
- 4.7.2 Roche Business Overview
- 4.7.3 Roche Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Roche Ephedrine Product Portfolio
- 4.7.5 Roche Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Ephedrine Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Novartis
- 4.9.1 Novartis Company Information
- 4.9.2 Novartis Business Overview
- 4.9.3 Novartis Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis Ephedrine Product Portfolio
- 4.9.5 Novartis Recent Developments
- 4.10 Sanofi
- 4.10.1 Sanofi Company Information
- 4.10.2 Sanofi Business Overview
- 4.10.3 Sanofi Ephedrine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi Ephedrine Product Portfolio
- 4.10.5 Sanofi Recent Developments
5 Global Ephedrine Market Scenario by Region
- 5.1 Global Ephedrine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ephedrine Sales by Region: 2021-2032
- 5.2.1 Global Ephedrine Sales by Region: 2021-2026
- 5.2.2 Global Ephedrine Sales by Region: 2027-2032
- 5.3 Global Ephedrine Revenue by Region: 2021-2032
- 5.3.1 Global Ephedrine Revenue by Region: 2021-2026
- 5.3.2 Global Ephedrine Revenue by Region: 2027-2032
- 5.4 North America Ephedrine Market Facts & Figures by Country
- 5.4.1 North America Ephedrine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ephedrine Sales by Country (2021-2032)
- 5.4.3 North America Ephedrine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ephedrine Market Facts & Figures by Country
- 5.5.1 Europe Ephedrine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ephedrine Sales by Country (2021-2032)
- 5.5.3 Europe Ephedrine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Ephedrine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ephedrine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ephedrine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ephedrine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ephedrine Market Facts & Figures by Country
- 5.7.1 South America Ephedrine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ephedrine Sales by Country (2021-2032)
- 5.7.3 South America Ephedrine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Ephedrine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ephedrine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ephedrine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ephedrine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ephedrine Sales by Type (2021-2032)
- 6.1.1 Global Ephedrine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Ephedrine Sales Market Share by Type (2021-2032)
- 6.2 Global Ephedrine Revenue by Type (2021-2032)
- 6.2.1 Global Ephedrine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ephedrine Revenue Market Share by Type (2021-2032)
- 6.3 Global Ephedrine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ephedrine Sales by Application (2021-2032)
- 7.1.1 Global Ephedrine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ephedrine Sales Market Share by Application (2021-2032)
- 7.2 Global Ephedrine Revenue by Application (2021-2032)
- 7.2.1 Global Ephedrine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ephedrine Revenue Market Share by Application (2021-2032)
- 7.3 Global Ephedrine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ephedrine Value Chain Analysis
- 8.1.1 Ephedrine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ephedrine Production Mode & Process
- 8.2 Ephedrine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ephedrine Distributors
- 8.2.3 Ephedrine Customers
9 Global Ephedrine Analyzing Market Dynamics
- 9.1 Ephedrine Industry Trends
- 9.2 Ephedrine Industry Drivers
- 9.3 Ephedrine Industry Opportunities and Challenges
- 9.4 Ephedrine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst